DIVA Laboratories, Ltd. (TPEX:4153)
33.55
-0.35 (-1.03%)
Feb 11, 2026, 1:30 PM CST
DIVA Laboratories Market Cap
DIVA Laboratories has a market cap or net worth of 1.97 billion as of February 13, 2026. Its market cap has decreased by -10.77% in one year.
Market Cap
1.97B
Enterprise Value
1.49B
Revenue
862.38M
Ranking
n/a
PE Ratio
23.62
Stock Price
33.55
Market Cap Chart
Since October 11, 2010, DIVA Laboratories's market cap has increased from 425.72M to 1.97B, an increase of 362.35%. That is a compound annual growth rate of 10.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.97B | -3.87% |
| Dec 31, 2025 | 2.05B | -8.76% |
| Dec 31, 2024 | 2.24B | 3.94% |
| Dec 29, 2023 | 2.16B | -9.25% |
| Dec 30, 2022 | 2.38B | 51.31% |
| Dec 30, 2021 | 1.57B | 8.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 268.14B |
| Caliway Biopharmaceuticals | 248.00B |
| Lotus Pharmaceutical | 76.92B |
| Heron Neutron Medical | 74.10B |
| Chunghwa Chemical Synthesis & Biotech | 2.07B |
| OK Biotech | 2.00B |
| Medical Imaging | 1.98B |
| Advagene Biopharma | 1.89B |